ARCHIVES

NCI Spent $381.2 Million On PR From 2006 to 2012, Vastly Outspending Other NIH, FDA Units

This article is from The Cancer Letter archive.

Vol. 39 No. 09 | March 1, 2013

Download PDF Visit The Full Archive

Related Articles

Overdiagnosis Since Advent Of Prostate Cancer Screening

September 25, 2009

NCI Advisory Group, Other Cancer Meetings For April, May

March 26, 1976

Wilms’ Tumor Survivors At High Risk Of Heart Failure

April 27, 2001

NCCS Networker Volume 7 Issue 4, Assembly Edition 1993

September 13, 1993

Schmidt Attempted To Answer Critics

October 1, 1976

NCI’s Plan to Limit Growth of Core Grants Prompts Smaller Cancer Centers to Cry Foul

May 11, 2012